Conavi Medical ( (TSE:CNVI) ) has provided an announcement.
Conavi Medical has engaged BND Projects Inc. for corporate development and strategic investment services, aiming to enhance its communication strategy and raise public awareness. This collaboration is expected to support Conavi in strengthening its market position and increasing visibility within the medical device industry, potentially impacting its operations and stakeholder engagement.
More about Conavi Medical
Conavi Medical is a commercial stage medical device company specializing in imaging technologies for minimally invasive cardiovascular procedures. Its key product, the Novasight Hybrid System, uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) for imaging coronary arteries, and has received regulatory approvals in the U.S., Canada, China, and Japan.
YTD Price Performance: 10.38%
Average Trading Volume: 5,587
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $8.01M
See more insights into CNVI stock on TipRanks’ Stock Analysis page.